Market Overview

Top 4 Stocks In The Drugs Wholesale Industry With The Highest Revenue

Related MCK
Mizuho Analysts Call McKesson's UDG Buyout 'Nice'
US Stock Futures Signal Lower Start On Wall Street
'Overdue' Dividend Increases (And Other Streaks In Peril) (Seeking Alpha)
Related CAH
Benzinga's Top Downgrades
Analyst: Cardinal Health Buying Spree To Boost FY17 EPS
Fund Managers Like These Dividend Stocks: Should You? (Investor's Business Daily)

Below are the top drugs wholesale stocks on the NYSE and the NASDAQ in terms of revenue.

The trailing-twelve-month revenue at McKesson (NYSE: MCK) is $122.73 billion. McKesson had $3.15 billion in total cash for the latest quarter.

The trailing-twelve-month revenue at Cardinal Health (NYSE: CAH) is $107.55 billion. Cardinal Health's PEG ratio is 1.16.

The trailing-twelve-month revenue at AmerisourceBergen (NYSE: ABC) is $81.00 billion. AmerisourceBergen's ROE for the same period is 23.22%.

The trailing-twelve-month revenue at Omnicare (NYSE: OCR) is $6.25 billion. Omnicare's operating margin for the same period is 8.45%.

Posted-In: Drugs Wholesale Industry Highest RevenueTrading Ideas


Related Articles (ABC + CAH)

View Comments and Join the Discussion!

Get Benzinga's Newsletters